CXCL17 Human shRNA Plasmid Kit (Locus ID 284340)
CAT#: TL307883
CXCL17 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 5,740.00
货期*
现货
规格
Cited in 1 publication. |
经常一起买 (3)
Specifications
Product Data | |
Product Name | CXCL17 Human shRNA Plasmid Kit (Locus ID 284340) |
Locus ID | 284340 |
UniProt ID | Q6UXB2 |
Synonyms | Dcip1; DMC; UNQ473; VCC-1; VCC1 |
Vector | pGFP-C-shLenti |
Format | Lentiviral plasmids |
Kit Components | CXCL17 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector(Gene ID = 284340). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-C-shLenti Vector, TR30021, included for free. |
RefSeq | NM_198477, NR_133910, NM_198477.1, NM_198477.2, BC112095, BC112095.1, BC093946, BM978124, NM_198477.3 |
Summary | The protein encoded by this gene is a mucosal chemokine that attracts immature dendritic cells and blood monocytes to the lungs. The encoded protein also promotes tumorigenesis through an angiogenic activity. Finally, this protein exhibits strong antimicrobial activity against E. coli, S. aureus, Salmonella, P. aeruginosa, and C. albicans. Two transcript variants, one protein-coding and the other non-protein coding, have been found for this gene. [provided by RefSeq, Dec 2015] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (1)
The use of this RNAi has been cited in the following citations: |
---|
The role and clinical significance of the CXCL17-CXCR8 (GPR35) axis in breast cancer.
,null,
Biochemical and biophysical research communications
,PubMed ID 28943434
[CXCL17]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...